Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:AGN)

Algernon Announces Warrant Extension

GlobeNewswire November 4, 2024

Algernon Pharmaceuticals Announces Closing of Private Placement

GlobeNewswire August 20, 2024

Algernon Pharmaceuticals Announces Increase to Private Placement

GlobeNewswire August 13, 2024

Algernon Pharmaceuticals Announces Private Placement

GlobeNewswire August 7, 2024

Algernon Pharmaceuticals Announces Closing of Private Placement

GlobeNewswire August 2, 2024

Algernon Pharmaceuticals Announces Increase to Private Placement

GlobeNewswire July 31, 2024

Algernon Pharmaceuticals Reports Results of Study Showing 93% Cough Suppression with Ifenprodil

GlobeNewswire July 16, 2024

Algernon Pharmaceuticals Announces Private Placement

GlobeNewswire July 11, 2024

Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services

GlobeNewswire May 21, 2024
View More News ››

Opinion & Analysis (CSE:AGN)

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

Dave Jackson June 16, 2021

Flying Under the Radar with a Possible COVID-19 Treatment

Stockhouse Editorial September 9, 2020

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

Streetwise Reports May 29, 2020

Buzz on the Bullboards: Coronavirus, Esports, and Uranium Plays

Omri Wallach April 16, 2020

Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

Omri Wallach March 19, 2020
View More Opinion ››

Bullboard Posts (CSE:AGN)

Today’s Depth Display on CSE

While trade price is hovering around 12 cents, if you remove the Quebec kids (Desjardins and National Bank), from the Depth Display, the...
nodaytrader - July 5, 2024

Yesterday’s Trading

Great was the joy in the sandbox yesterday at the return of Integral after a lengthy absence. Its single trade was an eye-watering $55...
nodaytrader - May 3, 2024

RE:Webinar Recap: $AGN CEO Chris Moreau and Radius Research

We learn in the video of Algernon's potential bring relief from suffering to millions of people around the world. we also learned of...
nodaytrader - May 1, 2024

Webinar Recap: $AGN CEO Chris Moreau and Radius Research

<< View Post To Watch Video >>
bmreed - April 22, 2024

Webinar $AGN CEO Chris Moreau Tue Apr 16 @ 4PM ET / 1PM PT

RESCHEDULED: Live Webinar - Algernon Pharmaceuticals $AGN w/ CEO Christopher Moreau Tuesday, April 16th at 4PM ET / 1PM PT Q&A...
bmreed - April 10, 2024

Tuesday’s Trading

Out of the country so catching up . Tursday's trading brought the price by one cent and the usual kids in the sandbox were involved...
nodaytrader - March 21, 2024
View more Bullboard ››

Biosenta Inc.

Biosenta Inc.

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and ...
View More »